← Back to S&P 500 Dashboard

CRL

INSUFFICIENT DATA

Charles River Laboratories Inte

Healthcare · Rank #491 · Analyzed Apr 20, 2026

$183.88

Current Price

$0.00

Intrinsic Value

-71.7%

Upside/Downside

0/10

Score

0.5/5

Quality

Analysis Summary

Valuation Consensus0/1 methods agree
Quality Score0.5/5.0
Framework RatingINSUFFICIENT DATA
Price vs Intrinsic ValueOvervalued by 71.7%

Fair Value Range

Low$52.06
Base (IV)$0.00
High$52.06

Entry Points

Conservative$52.06
Moderate$52.06
Aggressive$52.06

⚠️ Warnings

  • DCF discarded: negative profit margins
  • Insufficient data: fewer than 2 valuation methods

Quality & Moat Breakdown

Return on Equity-4.2% → 0/1.0
Debt LevelD/E 82 → 0/1.0
Revenue QualityGrowth -1.1%, margin Δ+0.2% +recovery → 0.5/1.0
Moat Strength1.0/5 → 0/1.0
Profit Margins-3.6% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.